Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Medicina
versión On-line ISSN 1561-302X
Resumen
SANCHEZ LINARES, Vladimir et al. HeberFERON in Treating Basosquamous Carcinoma. Rev. Cuban de Med [online]. 2023, vol.62, n.3 Epub 01-Sep-2023. ISSN 1561-302X.
Introduction:
Basal squamous cell carcinoma is an aggressive subtype of basal cell carcinoma composed of basaloid cells and areas of squamous cells with an intermediate transition zone, with a tendency to recur and metastasize.
Objective:
To describe the clinical case of a patient with a basal squamous cell carcinoma in the temporal region near the external canthus of the left eye.
Case report:
This paper reports a case of a female patient with a basal squamous cell carcinoma in the temporal region near the external canthus of her left eye with 30 mm diameter. HeberFERON was used with complete response when eliminating the tumor.
Conclusions:
HeberFERON is a non-surgical treatment option that can be used in facial basal squamous cell carcinoma that, due to its size, can cause mutilations or deformities in this area.
Palabras clave : HeberFERON; interferons; basal squamous carcinoma; metatypic carcinoma.